Home・Список акций・Progyny Inc

Progyny Inc

Открыт

СекторЗдравоохранение

28.03 -6.82

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

25.02

Макс.

30.93

Ключевые показатели
By Trading Economics
Доход	12M 24M
Продажи	10M 329M
P/E Средняя по отрасли	40.429 68.51
Прибыль на акцию	0.5
Рентабельность продаж	7.376
Сотрудники	835
EBITDA	19M 38M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+9.83% upside

Дивиденды
By Acuity
Следующий отчет о доходах	5 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	890M 2.4B
Предыдущая цена открытия	34.85
Предыдущая цена закрытия	28.03

Новостные настроения

By Acuity

13%

87%

22 / 340 Рейтинг в Healthcare

Progyny Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

6 авг. 2026 г., 23:02 UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31 июл. 2026 г., 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30 июл. 2026 г., 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29 июл. 2026 г., 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28 июл. 2026 г., 17:41 UTC

News

Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24 июл. 2026 г., 15:06 UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22 июл. 2026 г., 20:01 UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20 июл. 2026 г., 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Сравнение c конкурентами

Изменение цены

Progyny Inc Прогноз

Целевая цена

By TipRanks

9.83% рост

Прогноз на 12 месяцев

Средняя 33.18 USD 9.83%

Максимум 40 USD

Минимум 27 USD

Основано на мнении 11 аналитиков Wall Street, спрогнозировавших целевые цены для Progyny Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

11 ratings

Покупка

Удержание

Продажа

Основано на мнении 11 аналитиков, присваивавших рейтинги акциям Progyny Inc – Данные за последние 3 месяца.

Настроения

By Acuity

22 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.